Advantage of proton-radiotherapy for pediatric patients and adolescents with Hodgkin’s disease
Radiotherapy is frequently used in the therapy of lymphoma. Since lymphoma, for example Hodgkin’s disease, frequently affect rather young patients, the induction of secondary cancer or other long-term adverse effects after irradiation are important issues to deal with. Especially for mediastinal man...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
02 September 2019
|
| In: |
Radiation oncology
Year: 2019, Volume: 14 |
| ISSN: | 1748-717X |
| DOI: | 10.1186/s13014-019-1360-7 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1186/s13014-019-1360-7
|
| Author Notes: | S. Lautenschlaeger, G. Iancu, V. Flatten, K. Baumann, M. Thiemer, C. Dumke, K. Zink, H. Hauswald, D. Vordermark, C. Mauz-Körholz, R. Engenhart-Cabillic and F. Eberle |
| Summary: | Radiotherapy is frequently used in the therapy of lymphoma. Since lymphoma, for example Hodgkin’s disease, frequently affect rather young patients, the induction of secondary cancer or other long-term adverse effects after irradiation are important issues to deal with. Especially for mediastinal manifestations numerous organs and substructures at risk play a role. The heart, its coronary vessels and cardiac valves, the lungs, the thyroid and, for female patients, the breast tissue are only the most important organs at risk. In this study we investigated if proton-radiotherapy might reduce the dose delivered to the organs at risk and thus minimize the therapy-associated toxicity. |
|---|---|
| Item Description: | Gesehen am 21.01.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1748-717X |
| DOI: | 10.1186/s13014-019-1360-7 |